Third Party Financial Approval for PAH Medications

Advances in Pulmonary Hypertension
doi 10.21693/1933-088x-9.4.233
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pulmonary Hypertension Association

Related search

Expanded Use of PAH Medications

Advances in Pulmonary Hypertension
2008English

Lords of the Harvest: Third-Party Influence and Regulatory Approval of Genetically Modified Organisms

Academy of Management Journal
ManagementBusinessInternational ManagementStrategyInnovationAccountingManagement of Technology
2013English

Corporate Governance Impressions of Third Party Funds and Financial Performance

Wiga : Jurnal Penelitian Ilmu Ekonomi
2020English

Third Party Logistics

International Journal of Strategic Decision Sciences
2011English

Reshaping Third-Party Funding

SSRN Electronic Journal
2015English

ECOLOGY: Third-Party Parasitism

Science
MultidisciplinaryPhilosophy of ScienceHistory
2008English

Authentic Third-Party Data Publication

IFIP International Federation for Information Processing
2002English

Third Party Beneficiaries and Contractual Networks

SSRN Electronic Journal
2015English

Sustainable Risk Assessment Through the Analysis of Financial Losses From Third-Party Damage in Bridge Construction

Sustainability
DevelopmentManagementMonitoringEnvironmental ScienceRenewable EnergyEnergy EngineeringLawSustainabilityPlanningPolicyPower Technologythe EnvironmentGeography
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy